Kaye Horstman works in the New York office of Kirkland & Ellis LLP. Kaye is actively working on patent infringement cases involving pharmaceuticals and medical devices. Her experience includes litigation under the Hatch-Waxman Act and the Biologics Price Competition and Innovation Act as well as counseling clients on patent strategy.
Before attending law school, Kaye worked as a Scientific Advisor, also at Kirkland & Ellis LLP. In that role, she assisted in litigation and diligence matters involving biologics, small molecule drugs, medical devices, and biotechnology. Kaye also has experience in basic science research in microbiology and cost-effectiveness research on infectious disease treatment and prevention programs.
